Arvest Investments Inc. increased its position in shares of Molina Healthcare, Inc. (NYSE:MOH – Free Report) by 23.0% during the first quarter, Holdings Channel.com reports. The institutional investor owned 3,436 shares of the company’s stock after purchasing an additional 643 shares during the period. Arvest Investments Inc.’s holdings in Molina Healthcare were worth $1,132,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Smartleaf Asset Management LLC boosted its position in Molina Healthcare by 123.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 347 shares of the company’s stock worth $100,000 after purchasing an additional 192 shares during the period. Raymond James Financial Inc. bought a new position in Molina Healthcare during the fourth quarter worth $10,725,000. US Bancorp DE boosted its position in Molina Healthcare by 22.3% during the fourth quarter. US Bancorp DE now owns 1,993 shares of the company’s stock worth $580,000 after purchasing an additional 364 shares during the period. Nomura Holdings Inc. bought a new position in Molina Healthcare during the fourth quarter worth $547,000. Finally, Jacobs Levy Equity Management Inc. boosted its position in Molina Healthcare by 6.4% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 537,057 shares of the company’s stock worth $156,310,000 after purchasing an additional 32,273 shares during the period. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Molina Healthcare Stock Down 0.5%
MOH stock opened at $293.16 on Friday. The company has a market cap of $15.89 billion, a PE ratio of 14.35, a price-to-earnings-growth ratio of 1.06 and a beta of 0.57. The business has a 50-day simple moving average of $316.74 and a 200 day simple moving average of $307.19. Molina Healthcare, Inc. has a 52 week low of $262.32 and a 52 week high of $365.23. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the stock. Barclays reduced their price objective on shares of Molina Healthcare from $351.00 to $347.00 and set an “equal weight” rating for the company in a research report on Monday. Baird R W cut shares of Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Guggenheim assumed coverage on shares of Molina Healthcare in a research report on Wednesday, April 9th. They set a “neutral” rating for the company. Robert W. Baird reaffirmed a “neutral” rating and set a $375.00 price objective (up from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. Finally, Morgan Stanley initiated coverage on shares of Molina Healthcare in a research report on Monday. They issued an “overweight” rating and a $364.00 target price for the company. Nine investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, Molina Healthcare currently has an average rating of “Hold” and an average target price of $364.21.
Get Our Latest Research Report on Molina Healthcare
Insider Activity at Molina Healthcare
In other Molina Healthcare news, Director Richard M. Schapiro sold 669 shares of the business’s stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the transaction, the director now owns 11,244 shares of the company’s stock, valued at approximately $3,603,702. The trade was a 5.62% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the business’s stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the transaction, the chief executive officer now directly owns 257,715 shares of the company’s stock, valued at approximately $82,484,262.90. The trade was a 25.35% decrease in their position. The disclosure for this sale can be found here. 1.26% of the stock is owned by insiders.
About Molina Healthcare
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories
- Five stocks we like better than Molina Healthcare
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Stocks Set to Double—And There’s Still Time to Buy
- There Are Different Types of Stock To Invest In
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.